Trump considers own website for selling medications

In a surprising turn of events, the Trump administration is planning to launch its own website offering prescription drugs directly to consumers at discounted prices. This initiative, known under the project name TrumpRx, could bring the US government into direct competition with both large corporations and small pharmacies. Although the idea first came to light through Bloomberg, the decision on the implementation of the plan is still pending. The proposal is that patients can search for specific medications on the platform and contact providers who sell them. However, it remains unclear if and how exactly consumers would save money as a result. Pharmaceutical giants like Eli Lilly and Novo Nordisk already offer similar direct sales models, although the prices for some of their medications are often cheaper in other countries. Discussions about TrumpRx are expected to continue until the deadlines set by Trump. The government is currently pressuring pharmaceutical companies to lower the prices of common medications. Should the state actually intervene in the online sale of drugs, it could have significant impacts on the revenues of both large and small pharmacy chains. Tech giants like Amazon, which operates a low-cost online pharmacy, and Mark Cuban's Cost Plus Drugs could also be affected. The current discussions about reducing medication prices and possible advertising restrictions for pharmaceuticals are of great importance to the entire pharmaceutical industry. These measures are part of Trump's efforts to lower the costs of prescription drugs. Meanwhile, Health Secretary Robert F. Kennedy Jr. plans to address the potential danger of Tylenol concerning autism, which led to a loss in Kenvue stock value. Researchers sharply criticized the minister's statements.